These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 32468063

  • 1. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
    Luo Y, Ye J, Wei J, Zhang J, Li Y.
    Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
    [Abstract] [Full Text] [Related]

  • 2. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Sun Y, Zhang F, Wang L, Song X, Jing J, Zhang F, Yu S, Liu H.
    Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
    [Abstract] [Full Text] [Related]

  • 3. Risk scoring based on expression of long non‑coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis.
    Ye J, Wu S, Pan S, Huang J, Ge L.
    Oncol Rep; 2020 May; 43(5):1451-1466. PubMed ID: 32323856
    [Abstract] [Full Text] [Related]

  • 4. lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma.
    Wu S, Deng Y, Luo Y, Ye J, Liu Z.
    Asian Pac J Cancer Prev; 2021 Dec 01; 22(12):3741-3753. PubMed ID: 34967552
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.
    World J Gastroenterol; 2019 Jan 14; 25(2):220-232. PubMed ID: 30670911
    [Abstract] [Full Text] [Related]

  • 7. Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis.
    Ye J, Li H, Wei J, Luo Y, Liu H, Zhang J, Luo X.
    Asian Pac J Cancer Prev; 2020 Jun 01; 21(6):1787-1795. PubMed ID: 32592379
    [Abstract] [Full Text] [Related]

  • 8. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P, Wen DY, Li Q, He Y, Yang H, Chen G.
    Cell Physiol Biochem; 2018 Jun 01; 48(5):1953-1967. PubMed ID: 30092571
    [Abstract] [Full Text] [Related]

  • 9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ, Zhang J, Xu L, Liu FF.
    World J Gastroenterol; 2018 Aug 14; 24(30):3426-3439. PubMed ID: 30122881
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J, Wu L, Lei X, Shi K, Shi L, Shi Y.
    Bioengineered; 2021 Dec 14; 12(1):673-681. PubMed ID: 33622186
    [Abstract] [Full Text] [Related]

  • 15. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X, Yang C, Huang R, Han C, Yu T, Huang K, Liu X, Yu L, Zhu G, Su H, Wang X, Qin W, Deng J, Zeng X, Ye X, Peng T.
    Cell Physiol Biochem; 2018 Dec 14; 48(5):1854-1869. PubMed ID: 30092592
    [Abstract] [Full Text] [Related]

  • 16. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma.
    Liu H, Zhao P, Jin X, Zhao Y, Chen Y, Yan T, Wang J, Wu L, Sun Y.
    Mol Med Rep; 2019 Jul 14; 20(1):573-583. PubMed ID: 31115573
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y, Wang D, Xing R, Nie H, Mou Y, Zhang Y, Zhou X.
    Cancer Biomark; 2018 Jul 14; 23(1):95-106. PubMed ID: 29991128
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P, Huang Z, Mou T, Luo Y, Liu Y, Zhou B, Cao Z, Wu Z.
    BMC Cancer; 2021 Apr 20; 21(1):436. PubMed ID: 33879119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.